Tetsuya Mizutani

Tetsuya Mizutani

Auto-generated profile, based on publicly available information

Tetsuya Mizutani

Center for Infectious Disease Epidemiology and Prevention Research, Tokyo University of Agriculture and Technology, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
MKMai Kishimoto
Mai Kishimoto
STShinobu Tsuchiaka
Shinobu Tsuchiaka
SRSayed Samim Rahpaya
Sayed Samim Rahpaya
AHAyako Hasebe
Ayako Hasebe
KOKeiko Otsu
Keiko Otsu
TMTetsuya Mizutani
Tetsuya Mizutani
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

28 July 2015 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
MNMakoto Nagai
Makoto Nagai
TOTsutomu Omatsu
Tsutomu Omatsu
HAHiroshi Aoki
Hiroshi Aoki
KOKonosuke Otomaru
Konosuke Otomaru
TUTakehiko Uto
Takehiko Uto
TMTetsuya Mizutani
Tetsuya Mizutani

Verified
Journal Article
Open access
PDF file
Mohamed ElbadawyMohamed Elbadawy
Mohamed Elbadawy
YKYuki Kato
Yuki Kato
NSNagisa Saito
Nagisa Saito
KHKimika Hayashi
Kimika Hayashi
Amira AbugomaaAmira Abugomaa
Amira Abugomaa
TOTsutomu Omatsu
Tsutomu Omatsu
Various pathogens, such as Ebola virus, Marburg virus, Nipah virus, Hendra virus, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, are threatening human health worldwide. The natural hosts of these pathogens are thought to be bats. The rousette bat, a megabat, is thought to be a natural reservoir of filoviruses, including Ebola and Marburg viruses. Additionally, the rousette bat showed a transient infection in the experimental inoculation of SARS-CoV-2. In the current study, we established and characterized intestinal organoids from Leschenault’s rousette, Rousettus leschenaultii. The established organoids successfully recapitulated the characteristics of intestinal epithelial structure and morphology, and the appropriate supplements necessary for long-term stable culture were identified. The organoid showed susceptibility to Pteropine orthoreovirus (PRV) but not to SARS-CoV-2 in experimental inoculation. This is the first report of the establishment of an expandable organoid culture system of the rousette bat intestinal organoid and its sensitivity to bat-associated viruses, PRV and SARS-CoV-2. This organoid is a useful tool for the elucidation of tolerance mechanisms of the emerging rousette bat-associated viruses such as Ebola and Marburg virus.

11 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
STShinobu Tsuchiaka
Shinobu Tsuchiaka
YNYuki Naoi
Yuki Naoi
RIRyo Imai
Ryo Imai
TMTsuneyuki Masuda
Tsuneyuki Masuda
MIMika Ito
Mika Ito
MNMakoto Nagai
Makoto Nagai
To study the genetic diversity of enterovirus G (EV-G) among Japanese pigs, metagenomics sequencing was performed on fecal samples from pigs with or without diarrhea, collected between 2014 and 2016. Fifty-nine EV-G sequences, which were >5,000 nucleotides long, were obtained. By complete VP1 sequence analysis, Japanese EV-G isolates were classified into G1 (17 strains), G2 (four strains), G3 (22 strains), G4 (two strains), G6 (two strains), G9 (six strains), G10 (five strains), and a new genotype (one strain). Remarkably, 16 G1 and one G2 strain identified in diarrheic (23.5%; four strains) or normal (76.5%; 13 strains) fecal samples possessed a papain-like cysteine protease (PL-CP) sequence, which was recently found in the USA and Belgium in the EV-G genome, at the 2C–3A junction site. This paper presents the first report of the high prevalence of viruses carrying PL-CP in the EV-G population. Furthermore, possible inter- and intragenotype recombination events were found among EV-G strains, including G1-PL-CP strains. Our findings may advance the understanding of the molecular epidemiology and genetic evolution of EV-Gs.

1 January 2016 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
STShinobu Tsuchiaka
Shinobu Tsuchiaka
TMTsuneyuki Masuda
Tsuneyuki Masuda
SSSatoshi Sugimura
Satoshi Sugimura
SKSuguru Kobayashi
Suguru Kobayashi
NKNatsumi Komatsu
Natsumi Komatsu
TMTetsuya Mizutani
Tetsuya Mizutani
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 September 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
MOMami Oba
Mami Oba
WRWen Rongduo
Wen Rongduo
SASaito Akatsuki
Saito Akatsuki
TOTamaki Okabayashi
Tamaki Okabayashi
TYTomoko Yokota
Tomoko Yokota
TMTetsuya Mizutani
Tetsuya Mizutani
Natto, a traditional Japanese fermented soybean food, is well known to be nutritious and beneficial for health. In this study, we examined whether natto impairs infection by viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as bovine herpesvirus 1 (BHV-1). Interestingly, our results show that both SARS-CoV-2 and BHV-1 treated with a natto extract were fully inhibited infection to the cells. We also found that the glycoprotein D of BHV-1 was shown to be degraded by Western blot analysis and that a recombinant SARS-CoV-2 receptor-binding domain (RBD) was proteolytically degraded when incubated with the natto extract. In addition, RBD protein carrying a point mutation (UK variant N501Y) was also degraded by the natto extract. When the natto extract was heated at 100 °C for 10 min, the ability of both SARS-CoV-2 and BHV-1 to infect to the cells was restored. Consistent with the results of the heat inactivation, a serine protease inhibitor inhibited anti-BHV-1 activity caused by the natto extract. Thus, our findings provide the first evidence that the natto extract contains a protease(s) that inhibits viral infection through the proteolysis of the viral proteins.